Protocol of generation of tolerogenic dendritic cells affects their transcriptional and metabolic profiles leading to specific tolerogenic functions

MOLECULAR THERAPY METHODS & CLINICAL DEVELOPMENT · Published 2025-10-06 · DOI 10.1016/j.omtm.2025.101605

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.1016/j.omtm.2025.101605

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2025

Related articles

• Systemic mRNA-LNP administration in fetuses improves survival in a mouse model of spinal muscular atrophy · MOLECULAR THERAPY METHODS & CLINICAL DEVELOPMENT · 2025 · Same journal
• SLC20A1 knockout to stably express a fusogenic gibbon ape leukemia virus envelope glycoprotein for lentiviral vector production · MOLECULAR THERAPY METHODS & CLINICAL DEVELOPMENT · 2025 · Same journal
• Bilateral retinal rescue through unilateral AAV8-CYP4V2 gene delivery in Bietti crystalline dystrophy · MOLECULAR THERAPY METHODS & CLINICAL DEVELOPMENT · 2025 · Same journal
• Toward CAR-B cells for HIV-1 therapy · MOLECULAR THERAPY METHODS & CLINICAL DEVELOPMENT · 2025 · Same journal
• Leveraging the active conformation of LFA-1 as a potential target for hematological malignancies · MOLECULAR THERAPY METHODS & CLINICAL DEVELOPMENT · 2025 · Same journal
• Gene therapy supports long-term reconstitution of patient hematopoietic stem cells in deficiency of adenosine deaminase 2 · MOLECULAR THERAPY METHODS & CLINICAL DEVELOPMENT · 2025 · Same journal
• Modified AAV5 capsid for improved brain biodistribution following direct injection in preclinical models · MOLECULAR THERAPY METHODS & CLINICAL DEVELOPMENT · 2025 · Same journal
• Design of cationic ionizable lipids for the delivery of therapeutic nucleic acids · MOLECULAR THERAPY METHODS & CLINICAL DEVELOPMENT · 2025 · Same journal
• Should patients with pre-existing anti-AAV antibodies be excluded from receiving intrathecally delivered AAV vectors? · MOLECULAR THERAPY METHODS & CLINICAL DEVELOPMENT · 2025 · Same journal
• Intrathalamic delivery of adeno-associated viral vector expressing progranulin as gene therapy for GRN-related frontotemporal dementia · MOLECULAR THERAPY METHODS & CLINICAL DEVELOPMENT · 2025 · Same journal